Arkolith/Insider Trading/MLTX/Form 4

Reich Kristian

Chief Scientific OfficerMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Feb 29, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.5M
Net Open-Market Flow
-$6.5M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 28, 2024Sell(S)28K$55.00$1.5M42K
Feb 28, 2024Sell(S)32K$55.00$1.8M2.9M
Feb 27, 2024Sell(S)29K$55.00$1.6M3.0M
Feb 27, 2024Sell(S)29K$55.00$1.6M70K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-018671) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML